Verition Fund Management
LKFT

Verition Fund Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Verition Fund Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,270
Closed -$702K – 3665
2025
Q3 		$702K Sell
20,270
-11,043
-35% -$353K ﹤0.01% 2803
2025
Q2 		$876K Buy
31,313
+1,238
+4% +$33.2K ﹤0.01% 2572
2025
Q1 		$755K Buy
30,075
+12,386
+70% +$313K ﹤0.01% 2323
2024
Q4 		$486K Buy
+17,689
New +$493K ﹤0.01% 2502

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Verition Fund Management's LKFT Position: Q4 2025 in Review

Verition Fund Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 20,270 shares — an estimated $702K sold.

Verition Fund Management first reported a position in LKFT in Q4 2024 and held it in 4 quarters. The position peaked at $876K in Q2 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

  • Verition Fund Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 20,270 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $702K.
  • Verition Fund Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2024 and held it in 4 quarters.
  • Verition Fund Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $876K in Q2 2025.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.